Healthcare systems often emphasize initiating psychiatric medications without adequately preparing patients for discontinuation. This critical gap in medical guidance leaves individuals vulnerable to withdrawal effects and complications. Drug safety advocates argue that comprehensive patient education must address both beginning and ending antidepressant therapy, ensuring informed decision-making throughout the entire treatment journey and improving overall mental health outcomes.

Summary auto-generated by AI from the original publisher's content. Editorial standards.